Nuclear Medicine — Medicare Part B billing by state
8 physician groups whose primary specialty is Nuclear Medicine billed $14.1M to Medicare fee-for-service in 2024.
Calendar year 2024 · Medicare fee-for-service Part B
On this page: Billing by state · Top codes
Medicare billing by state
| State | Standardized payments | Medicare payments | Groups | Pay / group | Services | Benef.-episodes | Svc / group |
|---|---|---|---|---|---|---|---|
| Virginia | $7.0M | $6.8M | 1 | $6.8M | 28,537 | 5,484 | 28,537 |
| California | $4.7M | $4.6M | 1 | $4.6M | 73,671 | 14,618 | 73,671 |
| Florida | $2.3M | $2.4M | 1 | $2.4M | 161K | 17,100 | 161K |
| Connecticut | $154K | $161K | 1 | $161K | 3,080 | 2,734 | 3,080 |
| South Carolina | $63K | $57K | 1 | $57K | 3,797 | 1,302 | 3,797 |
| Arizona | $59K | $58K | 1 | $58K | 1,160 | 960 | 1,160 |
| Washington | $35K | $35K | 2 | $18K | 1,026 | 963 | 513 |
| North Carolina | $24K | $24K | 1 | $24K | 827 | 482 | 827 |
| Massachusetts | $21K | $21K | 1 | $21K | 258 | 257 | 258 |
Need this specialty's market in one document?
Register your interestEach group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.
All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.
Top codes by Medicare payments CY2024
6 more CPT-coded procedures — shown with a trial or subscription, under AMA licensing.
| Code | Medicare payments | Services | Largest state markets |
|---|---|---|---|
| Q9983 · Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries | $1.7M | 660 | VACAFLCTSC |
| A9595 · Piflufolastat f-18, diagnostic, 1 millicurie | $1.4M | 2,804 | VACAFLCTSC |
| A9584 · Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries | $679K | 322 | VACAFLCTSC |
| A9596 · Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | $504K | 623 | VACAFLCTSC |
| J9271 · Injection, pembrolizumab, 1 mg | $472K | 10,600 | VACAFLCTSC |
| J0897 · Injection, denosumab, 1 mg | $432K | 21,060 | VACAFLCTSC |
| J1437 · Injection, ferric derisomaltose, 10 mg top by services | $216K | 13,600 | VACAFLCTSC |
| Q5125 · Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram top by services | $22K | 58,560 | VACAFLCTSC |
| J1627 · Injection, granisetron, extended-release, 0.1 mg top by services | $20K | 4,500 | VACAFLCTSC |
| A9577 · Injection, gadobenate dimeglumine (multihance), per ml top by services | $7K | 5,218 | VACAFLCTSC |
| Q9967 · Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml top by services | $7K | 64,684 | VACAFLCTSC |
| J1453 · Injection, fosaprepitant, 1 mg top by services | $906 | 8,100 | VACAFLCTSC |